New Delhi, India — The State Bank of India (SBI) has released the SBI PO Pre Result 2026 on August 28, 2026, for the Probationary Officer PO Examination 2026. Candidates can check their preliminary result through the SBI portal using their Enrollment Number, Registration Number or Date of Birth. The recruitment is being conducted under Advertisement No. CRPD/PO/2026-27/09 for 1,500 Probationary Officer posts.
लेखक: Praveen Yadav
ISRO ICRB Scientist Engineer Recruitment 2026, Apply
ISRO ICRB Scientist / Engineer Recruitment 2026 has been announced for candidates seeking recruitment to Scientist/Engineer ‘SC’ positions in Electronics, Mechanical and Computer Science disciplines. The online application process started on August 27, 2026, and eligible candidates can apply until September 16, 2026, under Advertisement No. ISRO ICRB:03(EMC):2026.
RPSC APO Exam City Details 2026 Released, Check City
RPSC APO Exam City Details 2026 are now available for candidates appearing in the Rajasthan Public Service Commission Assistant Prosecution Officer examination. The preliminary exam is scheduled for September 2, 2026, while the RPSC APO Mains examination will be conducted on December 27, 2026.
PNB Bank LBO Admit Card 2026 Out, Download Hall Ticket
PNB Bank LBO Admit Card 2026 is now available for candidates who applied for the Local Bank Officer (LBO) recruitment. Punjab National Bank has issued the admit card on August 28, 2026, ahead of the online examination scheduled for September 6, 2026. The recruitment drive is being conducted for 545 Local Bank Officer positions.
RRB NTPC CBT-II Result 2026 Out, Check Score Card
RRB NTPC Graduate Level CBT-II Result 2026 is now available after the Railway Recruitment Board conducted the CBT-II examination on July 10. The result was released on August 27, 2026, for candidates who had qualified in CBT-I and appeared for the second stage of the recruitment process under CEN 06/2025.
Cipla Pune Licence Cancelled by Maharashtra FDA
Pune, India — Maharashtra’s Food and Drug Administration (FDA) has cancelled the drug sale licence of Cipla Pharma & Life Sciences Ltd.’s C&F facility in Wadki, Pune, following findings related to the storage, record-keeping and distribution of Reactin Plus Tablets.